Table 3 Association of AIP with sarcopenia.

From: Relationship between atherosclerotic burden and sarcopenia in U.S. adults: A cross-sectional study based on the NHANES database

Characteristic

Beta/OR

95%CI

P-value

Beta/OR

95%CI

P-value

Beta/OR

95%CI

P-value

Model 1

Model 2

Model 3

ASMBMI

         

AIP(continuity)

0.03

(0.01,0.05)

0.006

−0.07

(−0.08,−0.06)

<0.001

−0.02

(−0.03,−0.01)

<0.001

AIP level(categorical)

P for trend:0.044

P for trend:<0.001

P for trend:<0.001

Q1

Ref

Ref

Ref

Q2

0.01

 (−0.01,0.03)

0.339

−0.02

(−0.03,−0.01)

<0.001

0

(−0.01,0.01)

0.78

Q3

0.01

(−0.01,0.03)

0.397

−0.05

(−0.06,−0.04)

<0.001

−0.02

 (−0.03,−0.01)

0.001

Q4

0.02

(0,0.04)

0.039

−0.07

 (−0.08,−0.06)

<0.001

−0.02

 (−0.03,−0.01)

<0.001

Sarcopenia

   

AIP(continuity)

4.08

 (2.91,5.74)

<0.001

2.6

(1.78,3.81)

<0.001

1.05

(0.66,1.66)

0.844

AIP level(categorical)

P for trend:<0.001

P for trend:<0.001

P for trend:0.68

Q1

Ref

Ref

Ref

Q2

0.91

 (0.56,1.48)

0.701

0.78

(0.48,1.29)

0.342

0.52

 (0.3,0.88)

0.016

Q3

2.8

 (1.87,4.18)

<0.001

2.02

 (1.33,3.07)

0.001

1.18

 (0.75,1.87)

0.476

Q4

3.39

(2.29,5.03)

<0.001

2.04

(1.34,3.11)

0.001

0.84

(0.52,1.36)

0.477

  1. CI: confidence interval, OR: odds ratio, AIP: atherosclerotic index of plasma, ASMBMI: skeletal muscle mass adjusted by body mass index, Q1: -1.25~-0.3225, Q2: -0.3225~-0.1013, Q3: -0.1013~0.1479, Q4: 0.1479~1.61. Model 1 was unadjusted, Model 2 was adjusted for age, gender, race, and family income-to-poverty ratio. Model 3 was adjusted for age, gender, race, family income-to-poverty ratio, total cholesterol, systolic blood pressure, diastolic blood pressure, body mass index, hypertension, hypercholesterolemia, diabetes, arthritis, congestive heart failure, coronary heart disease, angina pectoris, stroke, emphysema, cancer, smoke, alcohol adjustments.